NHC agrees to buy 35 leased facilities from NHI for $560 million
NHC's subsidiary NHC/OP, L.P. agreed to buy the land and buildings of 32 skilled nursing facilities and three independent living facilities from National Health Investors, Inc. (NHI), which NHC currently leases under a Master Agreement to Lease. NHC can terminate the agreement for any reason through a review period ending May 29, 2026, with substantially all of its initial $5 million deposit refunded, and the deal is expected to close in the third quarter of 2026. NHC's chief executive says the deal is expected to be accretive to earnings and cash flow, but the filing gives no earnings or cash flow figures.
Key points
- Purchase price is $560 million, subject to adjustment, payable at closing, with no financing contingencies; NHC expects to fund part of it with a new credit facility.
- A $5 million initial deposit is due within five business days; an additional $15 million deposit is due within seven business days after the review period ends on May 29, 2026, if NHC has not terminated.
- NHC will keep operating the facilities except four Florida skilled nursing facilities, which are subleased to a third-party operator; the Master Lease will be terminated for the other facilities at closing.
- Closing is expected in the third quarter of 2026, subject to Hart-Scott-Rodino antitrust waiting period and other conditions; NHC's chairman Robert G. Adams sits on NHI's board and is not standing for reelection there.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 21, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.